BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MolMed S.p.A. 

via Olgettina, 58

Milan    20132  Italy
Phone: 39-0221277-1 Fax: 39-0221277-220


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
MolMed S.p.A. Signs an Agreement With GlaxoSmithKline (GSK) to Develop a Production Process for a Gene Therapy 8/5/2011 11:02:55 AM    More...
MolMed S.p.A. Release: Results of three Phase II Trials in Lung Cancer Indications Confirm Safety and Antitumour Activity of NGR-hTNF 6/3/2011 8:10:53 AM    More...
FDA Grants Orphan Drug Designation for MolMed S.p.A.'s Investigational Antiumour Drug 8/29/2008 10:20:28 AM    More...
MolMed S.p.A. Key Preliminary Results of Phase II Trials Presented 5/30/2008 11:27:51 AM    More...
Immunicon Corporation (IMMC) And MolMed S.p.A. Enter Research And Laboratory Services Agreements 9/28/2006 12:12:01 PM    More...
Takara Bio And MolMed S.p.A. Announce That Phase I/II Clinical Trial Of HSV-TK Gene Therapy Delivers Positive Results 12/15/2005 6:16:33 PM    More...
Takara Bio , MolMed S.p.A. Conclude R&D Agreement For HIV Gene Therapy Treatment 10/19/2005 5:13:13 PM    More...
Takara Bio's Research Partner MolMed S.p.A., European Medicines Agency Begin Discussions Concerning Phase III Clinical Studies Of HSV-TK Gene Therapy 10/19/2005 5:12:16 PM    More...